- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 24.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 24.91M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 25.43M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $28.26M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $27.93M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $29.35M |
| Capex | Q1 2026 · Mar 31, 2026 | $9.67M |
| Capex | Q1 2026 · Mar 31, 2025 | $9.04M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$33.46M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $42.72M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $941.34M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $941.5M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $3.67M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $3.68M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $142.24M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $222.62M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.39B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.36B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.37B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.39B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $487.98M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $473.37M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.83B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.82B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.42B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.35B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.22B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.18B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.53 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.94 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.60 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.94 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $122.62M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $120.58M |
| Net Income | Q1 2026 · Mar 31, 2026 | $62.95M |
| Net Income | Q1 2026 · Mar 31, 2025 | $49.44M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $95.16M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $81.32M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $273.67M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $251.75M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $816.85M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $793.84M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.09B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.05B |